Cresanto Global Limited shareholders have approved proposals to change the company name and shift its registered office from Uttar Pradesh to Maharashtra. The resolutions were passed through a postal ballot process conducted via remote e-voting, with results declared on June 3, 2026. These changes require consequential amendments to the Memorandum of Association and Articles of Association.

The postal ballot sought shareholder approval for three special resolutions. The first resolution covered the change of name and the associated amendments to the company's constitutional documents. The second resolution authorized the shifting of the registered office from Uttar Pradesh to Maharashtra. The third resolution addressed the alteration of the registered office clause in the Memorandum of Association.

Sachin Singh & Associates, Practicing Company Secretaries, were appointed as the scrutinizer for the process. The remote e-voting facility was provided by National Securities Depository Limited (NSDL). The cut-off date for determining eligible shareholders was April 24, 2026. The remote e-voting period commenced on May 5, 2026, and concluded on June 3, 2026.

The following table summarizes the voting results for the resolutions:

Cresanto Global Limited, formerly known as Raymed Labs Limited, is currently headquartered in Mumbai, Maharashtra, while its registered office is in Noida, Uttar Pradesh. The process was conducted in accordance with Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the Companies Act, 2013.

Cresanto Global Limited reported a net loss of ₹43.03 lakh for the financial year ended March 31, 2026, widening from a loss of ₹18.05 lakh in the previous year. The company's Board of Directors approved the audited financial results for the fourth quarter and fiscal year at a meeting held on May 28, 2026. Revenue from operations for FY26 stood at ₹5.39 lakh, compared to nil in the prior year, while total income decreased to ₹7.56 lakh from ₹52.59 lakh in FY25.

Financial Performance

The company's expenses for the year totaled ₹50.58 lakh, a decrease from ₹70.64 lakh in FY25. Finance costs for FY26 were reported at ₹15.86 lakh, while employee benefits expenses amounted to ₹14.00 lakh. For the quarter ended March 31, 2026, Cresanto Global recorded a net loss of ₹23.54 lakh on a total income of ₹0.17 lakh. Basic and diluted earnings per share for FY26 were negative at ₹1.01, compared to a negative ₹0.42 in the previous year.

Balance Sheet and Cash Flows

As of March 31, 2026, the company's total assets stood at ₹0.99 lakh, a significant reduction from ₹3.12 lakh in the previous year. Equity share capital remained unchanged at ₹427.35 lakh, while other equity decreased to a negative ₹729.16 lakh from a negative ₹686.14 lakh. Non-current liabilities, primarily borrowings, increased to ₹280.64 lakh from ₹237.12 lakh. Cash and cash equivalents improved to ₹0.62 lakh from ₹0.01 lakh at the end of FY25.

Auditor's Report

Statutory auditors M/s. K T P S & Co., Chartered Accountants, issued an unmodified opinion on the audited financial results for the quarter and year ended March 31, 2026. The audit report confirms that the financial statements present a true and fair view in conformity with Indian Accounting Standards (Ind AS). The trading window for dealing in the company's securities, which was closed since April 1, 2026, is set to reopen on May 30, 2026, in compliance with SEBI regulations.